Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

This study has been completed.
Information provided by (Responsible Party):
National Cancer Institute (NCI) Identifier:
First received: April 29, 2009
Last updated: March 14, 2014
Last verified: September 2013